More on Current Evidences on Probiotics as a Novel Treatment for Non-Alcoholic Fatty Liver Disease
Open Access
- 27 August 2013
- journal article
- Published by Brieflands in Hepatitis Monthly
- Vol. 13 (8) , e13780
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Microbiota and Gut–Liver AxisJournal of Pediatric Gastroenterology and Nutrition, 2013
- Probiotics as a Novel Treatment for Non-Alcoholic Fatty Liver Disease; A Systematic Review on the Current EvidencesHepatitis Monthly, 2013
- Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept studyAnnals of Hepatology, 2013
- Intestinal microbiota in patients with nonalcoholic fatty liver diseaseHepatology, 2013
- Characterization of Gut Microbiomes in Nonalcoholic Steatohepatitis (NASH) Patients: A Connection Between Endogenous Alcohol and NASHHepatology, 2012
- Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directionsItalian Journal of Pediatrics, 2012
- Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic SteatohepatitisDigestive Diseases and Sciences, 2011
- Effects of Lactobacillus rhamnosus Strain GG in Pediatric Obesity‐related Liver DiseaseJournal of Pediatric Gastroenterology and Nutrition, 2011
- The Effect of a Probiotic on Hepatic SteatosisJournal of Clinical Gastroenterology, 2008
- Beneficial Effects of a Probiotic VSL#3 on Parameters of Liver Dysfunction in Chronic Liver DiseasesJournal of Clinical Gastroenterology, 2005